Prescription drugs
  



Oprelvekin - Systemic

Brand Names

Neumega, interleukin-11, recombinant, rIL-11
Oprelvekin *** Before Using *** How to Use *** Fore Safe Use *** Side Effects

Before Using

In deciding to using a medication, the chance of taking the drug must be weighed against the good it will do. This is a decision you will make. For oprelvekin, the following must be considered

Allergic reaction

Tell your family doctor if you have any unusual or allergy to oprelvekin. Also tell your health care professional if you are allergic to any other substances, such as foods, preservatives, or dyes.

Pregnancy care

Oprelvekin has not been studied in pregnant women. However, in rats and rabbits this drug was found to cause harmful effects on the fetus, including miscarriages and poor growth. It has not been found to cause birth defects in pets.

Breast-feeding problem

It is not known whether oprelvekin passes into breast milk. Discuss with your family doctor whether or not you must breast-feed during treat with this drug.

Use for Children

Oprelvekin has causing joint and tendon problems in pets and there is a possibility it could also cause these effects in child receiving it. Discuss these possible effects with your family doctor.

Elderly care

This drug has been tested and has not been shown to cause various side effects or problems in elderly people than it does in adults people.

Drug interactions

Although certain medication must not be using together at all, in other cases two various medication may be using together even if an interaction might occur. In these cases, your family doctor may want to change the dose, or other precautions may be necessary. Tell your health care professional if you are taking any other prescription or nonprescription - over-the-counter "OTC " drug.

Other Information for using

The presence of other medical problems may effect the use of oprelvekin. Make sure you tell your family doctor if you have any other medical problems, especially:








  

Popular links
ÑÓÊÐÀÒ
ÑÓÊÑÈËÅÏ
ÑÓËÜÏÅÐÀÇÎÍ
ÑÓËÜÏÈÐÈÄ
ÑÓËÜÔÀËÅÍ
ÑÓËÜÔÀÑÀËÀÇÈÍ
ÑÓÌÀÇÈÄ
ÑÓÑÒÀÊ ÔÎÐÒÅ